Cover Image
Market Research Report

Global Market Study on Non-infectious Macular Edema Treatment: Companies to Launch Biosimilars of First Anti-VEGF Lucentis by 2020

Published by Persistence Market Research Product code 658705
Published Content info 323 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Market Study on Non-infectious Macular Edema Treatment: Companies to Launch Biosimilars of First Anti-VEGF Lucentis by 2020
Published: May 30, 2018 Content info: 323 Pages
Description

Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

Current expenditure on health, % of gross domestic product

Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)

Annual growth rate of current expenditure on health, per capita, in real terms

Out-of-pocket expenditure, % of current expenditure on health

Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)

Physicians, Density per 1000 population (head counts)

Nurses, Density per 1000 population (head counts)

Total hospital beds, per 1000 population

Curative (acute) care beds, per 1000 population

Medical technology, Magnetic Resonance Imaging units, total, per million population

Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

PMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Table of Contents

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Primary Research - Verbatim
  • 2.4. Global Non-infectious Macular Edema Treatment Market - Trade Overview

3. Non-infectious Macular Edema Treatment Market Overview

  • 3.1. Patient's Journey Through Non-infectious Uveitic Macular Edema Treatment Process
  • 3.2. Management Flowchart For Non-infectious Uveitis Macular Edema Treatment
  • 3.3. Patient's Journey Through Diabetic Macular Edema Treatment Process
  • 3.4. Management Flowchart For Diabetic Macular Edema Treatment
  • 3.5. Patient's Journey Through Retinal Vein Occlusion Macular Edema Treatment Process
  • 3.6. Management Flowchart For Retinal Vein Occlusion Macular Edema Treatment
  • 3.7. Epidemiology
    • 3.7.1. Non-infectious Uveitis Macular Edema
    • 3.7.2. Diabetic Macular Edema
    • 3.7.3. Retinal Vain Occlusion with Macular Edema
  • 3.8. Impact Analysis
    • 3.8.1. Anti-VEGF Therapies
    • 3.8.2. Corticosteroids
    • 3.8.3. Immunosuppressant
    • 3.8.4. Biologics
  • 3.9. U.S. Key Regulations - Macular Edema
  • 3.10. Macular Edema Drugs: U.S. FDA Regulatory Scenario
  • 3.11. Global Macular Edema Market Pipeline Analysis
  • 3.12. Treatment Summary
  • 3.13. Macular Edema Treatment Market - Supply Chain Analysis
  • 3.14. Economic and Clinical Value Measures in Pricing of Macular Edema Treatment

4. Non-infectious Macular Edema Treatment Market Opportunity Analysis

  • 4.1. Macro-Economic Factors
  • 4.2. Opportunity Analysis

5. Market Background

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
    • 5.1.2. Restraints
    • 5.1.3. Trends
  • 5.2. Reimbursement Landscape
  • 5.3. Regulatory Scenario

6. North America Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 6.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 6.4.1. Anti-VEGF
    • 6.4.2. Corticosteroids
    • 6.4.3. Immunosuppressant
    • 6.4.4. Biologics
    • 6.4.5. Others
  • 6.5. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 6.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 6.6.1. Oral
    • 6.6.2. Parenteral
    • 6.6.3. topical
  • 6.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 6.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 6.8.1. Non-infectious Uveitic Macular Edema
    • 6.8.2. Diabetic Macular Edema
    • 6.8.3. Retinal Vein Occlusion with Macular Edema
  • 6.9. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 6.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012-2017
    • 6.10.1. Hospital Pharmacies
    • 6.10.2. Retail Pharmacies
    • 6.10.3. Online Pharmacies
  • 6.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 6.12. Drivers and Restraints: Impact Analysis
  • 6.13. Market Attractiveness Analysis
    • 6.13.1. By Country
    • 6.13.2. By Drug Type
    • 6.13.3. By Route of Administration
    • 6.13.4. By Indication
    • 6.13.5. By Distribution Channel
  • 6.14. Drivers and Restraints - Impact Analysis

7. Latin America Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 7.2.1. Brazil
    • 7.2.2. Mexico
    • 7.2.3. Rest of Latin America
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 7.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 7.4.1. Anti-VEGF
    • 7.4.2. Corticosteroids
    • 7.4.3. Immunosuppressant
    • 7.4.4. Biologics
    • 7.4.5. Others
  • 7.5. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 7.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 7.6.1. Oral
    • 7.6.2. Parenteral
    • 7.6.3. topical
  • 7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 7.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 7.8.1. Non-infectious Uveitic Macular Edema
    • 7.8.2. Diabetic Macular Edema
    • 7.8.3. Retinal Vein Occlusion with Macular Edema
  • 7.9. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 7.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012-2017
    • 7.10.1. Hospital Pharmacies
    • 7.10.2. Retail Pharmacies
    • 7.10.3. Online Pharmacies
  • 7.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 7.12. Drivers and Restraints: Impact Analysis
  • 7.13. Market Attractiveness Analysis
    • 7.13.1. By Country
    • 7.13.2. By Drug Type
    • 7.13.3. By Route of Administration
    • 7.13.4. By Indication
    • 7.13.5. By Distribution Channel
  • 7.14. Drivers and Restraints - Impact Analysis

8. Europe Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 8.2.1. Germany
    • 8.2.2. U.K.
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Russia
    • 8.2.7. Rest of Europe
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 8.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 8.4.1. Anti-VEGF
    • 8.4.2. Corticosteroids
    • 8.4.3. Immunosuppressant
    • 8.4.4. Biologics
    • 8.4.5. Others
  • 8.5. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 8.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 8.6.1. Oral
    • 8.6.2. Parenteral
    • 8.6.3. topical
  • 8.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 8.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 8.8.1. Non-infectious Uveitic Macular Edema
    • 8.8.2. Diabetic Macular Edema
    • 8.8.3. Retinal Vein Occlusion with Macular Edema
  • 8.9. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 8.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 8.10.1. Hospital Pharmacies
    • 8.10.2. Retail Pharmacies
    • 8.10.3. Online Pharmacies
  • 8.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 8.12. Drivers and Restraints: Impact Analysis
  • 8.13. Market Attractiveness Analysis
    • 8.13.1. By Country
    • 8.13.2. By Drug Type
    • 8.13.3. By Route of Administration
    • 8.13.4. By Indication
    • 8.13.5. By Distribution Channel
  • 8.14. Drivers and Restraints - Impact Analysis

9. APAC Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 9.2.1. China
    • 9.2.2. Australia
    • 9.2.3. India
    • 9.2.4. Rest of APAC
  • 9.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 9.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 9.4.1. Anti-VEGF
    • 9.4.2. Corticosteroids
    • 9.4.3. Immunosuppressant
    • 9.4.4. Biologics
    • 9.4.5. Others
  • 9.5. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 9.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 9.6.1. Oral
    • 9.6.2. Parenteral
    • 9.6.3. topical
  • 9.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 9.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 9.8.1. Non-infectious Uveitic Macular Edema
    • 9.8.2. Diabetic Macular Edema
    • 9.8.3. Retinal Vein Occlusion with Macular Edema
  • 9.9. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 9.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 9.10.1. Hospital Pharmacies
    • 9.10.2. Retail Pharmacies
    • 9.10.3. Online Pharmacies
  • 9.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 9.12. Drivers and Restraints: Impact Analysis
  • 9.13. Market Attractiveness Analysis
    • 9.13.1. By Country
    • 9.13.2. By Drug Type
    • 9.13.3. By Route of Administration
    • 9.13.4. By Indication
    • 9.13.5. By Distribution Channel
  • 9.14. Drivers and Restraints - Impact Analysis

10. Japan Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 10.2.1. Anti-VEGF
    • 10.2.2. Corticosteroids
    • 10.2.3. Immunosuppressant
    • 10.2.4. Biologics
    • 10.2.5. Others
  • 10.3. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 10.4. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 10.4.1. Oral
    • 10.4.2. Parenteral
    • 10.4.3. topical
  • 10.5. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 10.6. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 10.6.1. Non-infectious Uveitic Macular Edema
    • 10.6.2. Diabetic Macular Edema
    • 10.6.3. Retinal Vein Occlusion with Macular Edema
  • 10.7. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 10.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 10.8.1. Hospital Pharmacies
    • 10.8.2. Retail Pharmacies
    • 10.8.3. Online Pharmacies
  • 10.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 10.10. Drivers and Restraints: Impact Analysis
  • 10.11. Market Attractiveness Analysis
    • 10.11.1. By Drug Type
    • 10.11.2. By Route of Administration
    • 10.11.3. By Indication
    • 10.11.4. By Distribution Channel
  • 10.12. Drivers and Restraints - Impact Analysis

11. MEA Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
    • 11.2.1. GCC Countries
    • 11.2.2. South Africa
    • 11.2.3. Rest of MEA
  • 11.3. Market Size (US$ Mn) Forecast By Country, 2018-2026
  • 11.4. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 11.4.1. Anti-VEGF
    • 11.4.2. Corticosteroids
    • 11.4.3. Immunosuppressant
    • 11.4.4. Biologics
    • 11.4.5. Others
  • 11.5. Market Size (US$ Mn) Forecast By Drug Type, 2018-2026
  • 11.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 11.6.1. Oral
    • 11.6.2. Parenteral
    • 11.6.3. topical
  • 11.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
  • 11.8. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 11.8.1. Non-infectious Uveitic Macular Edema
    • 11.8.2. Diabetic Macular Edema
    • 11.8.3. Retinal Vein Occlusion with Macular Edema
  • 11.9. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 11.10. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 11.10.1. Hospital Pharmacies
    • 11.10.2. Retail Pharmacies
    • 11.10.3. Online Pharmacies
  • 11.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 11.12. Drivers and Restraints: Impact Analysis
  • 11.13. Market Attractiveness Analysis
    • 11.13.1. By Country
    • 11.13.2. By Drug Type
    • 11.13.3. By Route of Administration
    • 11.13.4. By Indication
    • 11.13.5. By Distribution Channel
  • 11.14. Drivers and Restraints - Impact Analysis

12. Forecast Factors: Relevance and Impact and Forecast Assumptions

13. Market Structure Analysis

  • 13.1. Market Structure by Tier of Companies

14. Competition Analysis

  • 14.1. Competition Dashboard
  • 14.2. Competition Benchmarking
  • 14.3. Company Deep Dive
    • 14.3.1. Allergan, Plc.
      • 14.3.1.1. Overview
      • 14.3.1.2. Product and Infection Type Portfolio
      • 14.3.1.3. Production Footprint
      • 14.3.1.4. Sales Footprint
      • 14.3.1.5. Channel Footprint
      • 14.3.1.6. Strategy
        • 14.3.1.6.1.1. Marketing Strategy
        • 14.3.1.6.1.2. Product Strategy
        • 14.3.1.6.1.3. Channel Strategy
    • 14.3.2. Pfizer, Inc.
      • 14.3.2.1. Overview
      • 14.3.2.2. Product and Infection Type Portfolio
      • 14.3.2.3. Production Footprint
      • 14.3.2.4. Sales Footprint
      • 14.3.2.5. Channel Footprint
      • 14.3.2.6. Strategy
        • 14.3.2.6.1.1. Marketing Strategy
        • 14.3.2.6.1.2. Product Strategy
        • 14.3.2.6.1.3. Channel Strategy
    • 14.3.3. Novartis AG
      • 14.3.3.1. Overview
      • 14.3.3.2. Product and Infection Type Portfolio
      • 14.3.3.3. Production Footprint
      • 14.3.3.4. Sales Footprint
      • 14.3.3.5. Channel Footprint
      • 14.3.3.6. Strategy
        • 14.3.3.6.1.1. Marketing Strategy
        • 14.3.3.6.1.2. Product Strategy
        • 14.3.3.6.1.3. Channel Strategy
    • 14.3.4. F. Hoffman - La Roche Ltd.
      • 14.3.4.1. Overview
      • 14.3.4.2. Product and Infection Type Portfolio
      • 14.3.4.3. Production Footprint
      • 14.3.4.4. Sales Footprint
      • 14.3.4.5. Channel Footprint
      • 14.3.4.6. Strategy
        • 14.3.4.6.1.1. Marketing Strategy
        • 14.3.4.6.1.2. Product Strategy
        • 14.3.4.6.1.3. Channel Strategy
    • 14.3.5. AbbVie Inc.
      • 14.3.5.1. Overview
      • 14.3.5.2. Product and Infection Type Portfolio
      • 14.3.5.3. Production Footprint
      • 14.3.5.4. Sales Footprint
      • 14.3.5.5. Channel Footprint
      • 14.3.5.6. Strategy
        • 14.3.5.6.1.1. Marketing Strategy
        • 14.3.5.6.1.2. Product Strategy
        • 14.3.5.6.1.3. Channel Strategy
    • 14.3.6. Bayer AG
      • 14.3.6.1. Overview
      • 14.3.6.2. Product and Infection Type Portfolio
      • 14.3.6.3. Production Footprint
      • 14.3.6.4. Sales Footprint
      • 14.3.6.5. Channel Footprint
      • 14.3.6.6. Strategy
        • 14.3.6.6.1.1. Marketing Strategy
        • 14.3.6.6.1.2. Product Strategy
        • 14.3.6.6.1.3. Channel Strategy
    • 14.3.7. Valeant Pharmaceuticals Inc.
      • 14.3.7.1. Overview
      • 14.3.7.2. Product and Infection Type Portfolio
      • 14.3.7.3. Production Footprint
      • 14.3.7.4. Sales Footprint
      • 14.3.7.5. Channel Footprint
      • 14.3.7.6. Strategy
        • 14.3.7.6.1.1. Marketing Strategy
        • 14.3.7.6.1.2. Product Strategy
        • 14.3.7.6.1.3. Channel Strategy
    • 14.3.8. Alimera Sciences Inc.
      • 14.3.8.1. Overview
      • 14.3.8.2. Product and Infection Type Portfolio
      • 14.3.8.3. Production Footprint
      • 14.3.8.4. Sales Footprint
      • 14.3.8.5. Channel Footprint
      • 14.3.8.6. Strategy
        • 14.3.8.6.1.1. Marketing Strategy
        • 14.3.8.6.1.2. Product Strategy
        • 14.3.8.6.1.3. Channel Strategy
    • 14.3.9. Clearside Biomedical, Inc.
      • 14.3.9.1. Overview
      • 14.3.9.2. Product and Infection Type Portfolio
      • 14.3.9.3. Production Footprint
      • 14.3.9.4. Sales Footprint
      • 14.3.9.5. Channel Footprint
      • 14.3.9.6. Strategy
        • 14.3.9.6.1.1. Marketing Strategy
        • 14.3.9.6.1.2. Product Strategy
        • 14.3.9.6.1.3. Channel Strategy
    • 14.3.10. Amgen, Inc.
      • 14.3.10.1. Overview
      • 14.3.10.2. Product and Infection Type Portfolio
      • 14.3.10.3. Production Footprint
      • 14.3.10.4. Sales Footprint
      • 14.3.10.5. Channel Footprint
      • 14.3.10.6. Strategy
        • 14.3.10.6.1.1. Marketing Strategy
        • 14.3.10.6.1.2. Product Strategy
        • 14.3.10.6.1.3. Channel Strategy

15. Global Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026, By Region

  • 15.1. Introduction/Key Findings
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013-2017
  • 15.3. Market Size (US$ Mn) Forecast By Region, 2018-2026
    • 15.3.1. North America
    • 15.3.2. Latin America
    • 15.3.3. Europe
    • 15.3.4. APAC
    • 15.3.5. Japan
    • 15.3.6. Middle East and Africa (MEA)
  • 15.4. Market Attractiveness Analysis By Region

16. Global Non-infectious Macular Edema Treatment Analysis 2013-2017 and Forecast 2018-2026, By Drug Type

  • 16.1. Introduction/Key Findings
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013-2017
    • 16.2.1. Anti-VEGF
    • 16.2.2. Corticosteroids
    • 16.2.3. Immunosuppressant
    • 16.2.4. Biologics
    • 16.2.5. Others
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Drug Type, 2018-2026
  • 16.4. Market Attractiveness Analysis By Drug Type

17. Global Non-infectious Macular Edema Treatment Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration

  • 17.1. Introduction/Key Findings
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
    • 17.2.1. Oral
    • 17.2.2. Parenteral
    • 17.2.3. Topical
  • 17.3. Market Size (US$ Mn) and Volume Forecast By Route of Administration, 2018-2026
  • 17.4. Market Attractiveness Analysis By Route of Administration

18. Global Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026, By Indication

  • 18.1. Introduction/Key Findings
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2013-2017
    • 18.2.1. Non-infectious Uveitic Macular Edema
    • 18.2.2. Diabetic Macular Edema
    • 18.2.3. Retinal Vein Occlusion with Macular Edema
  • 18.3. Market Size (US$ Mn) Forecast By Indication, 2018-2026
  • 18.4. Market Attractiveness Analysis By Indication

19. Global Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

  • 19.1. Introduction/Key Findings
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
    • 19.2.1. Hospital Pharmacies
    • 19.2.2. Retail Pharmacies
    • 19.2.3. Online Pharmacies
  • 19.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2026
  • 19.4. Market Attractiveness Analysis By Distribution Channel

20. Global Non-infectious Macular Edema Treatment Market Analysis 2013-2017 and Forecast 2018-2026

  • 20.1. Market Value Share Analysis By All Segment
  • 20.2. Y-o-Y Growth Analysis By All Segment
  • 20.3. Absolute $ Opportunity

21. Research Methodology

List of Table

  • Table 01: North America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 02: North America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 03: North America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration
  • Table 04: North America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 05: North America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 06: Latin America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 07: Latin America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 08: Latin America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration
  • Table 09: Latin America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 10: Latin America Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 11: Europe Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 12: Europe Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 13: Europe Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration
  • Table 14: Europe Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 15: Europe Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 16: APAC Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 17: APAC Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 18: APAC Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration
  • Table 19: APAC Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 20: APAC Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 21: Japan Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 22: Japan Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration
  • Table 23: Japan Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 24: Japan Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 25: MEA Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
  • Table 26: MEA Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 27: MEA Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration
  • Table 28: MEA Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 29: MEA Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
  • Table 30: Global Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis-2013-2017 and Forecast 2018-2026, By Region
  • Table 31: Global Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
  • Table 32: Global Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Route of Administration
  • Table 33: Global Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication
  • Table 34: Global Non-infectious Macular Edema Treatment Market Size Analysis (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

List of Figure

  • Figure 01: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 02: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 03: U.S. Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 04: U.S. Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 05: Canada Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 06: Canada Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 07: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Anti-VEGF, 2013-2017
  • Figure 08: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Anti-VEGF, 2018-2026
  • Figure 09: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Corticosteroids, 2013-2017
  • Figure 10: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Corticosteroids, 2018-2026
  • Figure 11: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Immunosuppressant, 2013-2017
  • Figure 12: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Immunosuppressant, 2018-2026
  • Figure 13: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Biologics, 2013-2017
  • Figure 14: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Biologics, 2018-2026
  • Figure 15: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Others, 2018-2026
  • Figure 16: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Others, 2018-2026
  • Figure 17: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Oral Administration, 2013-2017
  • Figure 18: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Oral Administration, 2018-2026
  • Figure 19: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Parenteral Administration, 2013-2017
  • Figure 20: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Parenteral Administration, 2018-2026
  • Figure 21: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Topical Administration, 2013-2017
  • Figure 22: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Topical Administration, 2018-2026
  • Figure 23: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Non-infectious Uveitic Macular Edema, 2013-2017
  • Figure 24: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Non-infectious Uveitic Macular Edema, 2018-2026
  • Figure 25: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Diabetic Macular Edema, 2013-2017
  • Figure 26: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Diabetic Macular Edema, 2018-2026
  • Figure 27: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retinal Vein Occlusion With Macular Edema, 2013-2017
  • Figure 28: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retinal Vein Occlusion With Macular Edema, 2018-2026
  • Figure 29: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Hospital Pharmacies, 2013-2017
  • Figure 30: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2026
  • Figure 31: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retail Pharmacies, 2013-2017
  • Figure 32: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retail Pharmacies, 2018-2026
  • Figure 33: North America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Online Pharmacies, 2013-2017
  • Figure 34: North America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Online Pharmacies, 2018-2026
  • Figure 35: North America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Country
  • Figure 36: North America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Drug Type
  • Figure 37: North America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Route of Administration
  • Figure 38: North America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Indication
  • Figure 39: North America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Distribution Channel
  • Figure 40: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 41: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 42: Brazil Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 43: Brazil Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 44: Mexico Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 45: Mexico Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 46: Rest of Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 47: Rest of Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 48: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Anti-VEGF, 2013-2017
  • Figure 49: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Anti-VEGF, 2018-2026
  • Figure 50: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Corticosteroids, 2013-2017
  • Figure 51: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Corticosteroids, 2018-2026
  • Figure 52: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Immunosuppressant, 2013-2017
  • Figure 53: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Immunosuppressant, 2018-2026
  • Figure 54: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Biologics, 2013-2017
  • Figure 55: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Biologics, 2018-2026
  • Figure 56: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Others, 2018-2026
  • Figure 57: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Others, 2018-2026
  • Figure 58: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Oral Administration, 2013-2017
  • Figure 59: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Oral Administration, 2018-2026
  • Figure 60: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Parenteral Administration, 2013-2017
  • Figure 61: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Parenteral Administration, 2018-2026
  • Figure 62: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Topical Administration, 2013-2017
  • Figure 63: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Topical Administration, 2018-2026
  • Figure 64: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Non-infectious Uveitic Macular Edema, 2013-2017
  • Figure 65: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Non-infectious Uveitic Macular Edema, 2018-2026
  • Figure 66: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Diabetic Macular Edema, 2013-2017
  • Figure 67: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Diabetic Macular Edema, 2018-2026
  • Figure 68: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retinal Vein Occlusion With Macular Edema, 2013-2017
  • Figure 69: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retinal Vein Occlusion With Macular Edema, 2018-2026
  • Figure 70: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Hospital Pharmacies, 2013-2017
  • Figure 71: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2026
  • Figure 72: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retail Pharmacies, 2013-2017
  • Figure 73: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retail Pharmacies, 2018-2026
  • Figure 74: Latin America Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Online Pharmacies, 2013-2017
  • Figure 75: Latin America Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Online Pharmacies, 2018-2026
  • Figure 76: Latin America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Country
  • Figure 77: Latin America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Drug Type
  • Figure 78: Latin America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Route of Administration
  • Figure 79: Latin America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Indication
  • Figure 80: Latin America Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Distribution Channel
  • Figure 81: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 82: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 83: Germany Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 84: Germany Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 85: U.K. Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 86: U.K. Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 87: France Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 88: France Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by 2018-2026
  • Figure 89: Italy Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 90: Italy Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 91: Spain Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 92: Spain Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by 2018-2026
  • Figure 93: Russia Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 94: Russia Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 95: Rest of Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2018-2026
  • Figure 96: Rest of Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 97: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Anti-VEGF, 2013-2017
  • Figure 98: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Anti-VEGF, 2018-2026
  • Figure 99: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Corticosteroids, 2013-2017
  • Figure 100: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Corticosteroids, 2018-2026
  • Figure 101: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Immunosuppressant, 2013-2017
  • Figure 102: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Immunosuppressant, 2018-2026
  • Figure 103: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Biologics, 2013-2017
  • Figure 104: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Biologics, 2018-2026
  • Figure 105: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Others, 2018-2026
  • Figure 106: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Others, 2018-2026
  • Figure 107: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Oral Administration, 2013-2017
  • Figure 108: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Oral Administration, 2018-2026
  • Figure 109: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Parenteral Administration, 2013-2017
  • Figure 110: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Parenteral Administration, 2018-2026
  • Figure 111: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Topical Administration, 2013-2017
  • Figure 112: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Topical Administration, 2018-2026
  • Figure 113: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Non-infectious Uveitic Macular Edema, 2013-2017
  • Figure 114: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Non-infectious Uveitic Macular Edema, 2018-2026
  • Figure 115: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Diabetic Macular Edema, 2013-2017
  • Figure 116: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Diabetic Macular Edema, 2018-2026
  • Figure 117: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retinal Vein Occlusion With Macular Edema, 2013-2017
  • Figure 118: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retinal Vein Occlusion With Macular Edema, 2018-2026
  • Figure 119: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Hospital Pharmacies, 2013-2017
  • Figure 120: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2026
  • Figure 121: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retail Pharmacies, 2013-2017
  • Figure 122: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retail Pharmacies, 2018-2026
  • Figure 123: Europe Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Online Pharmacies, 2013-2017
  • Figure 124: Europe Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Online Pharmacies, 2018-2026
  • Figure 125: Europe Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Country
  • Figure 126: Europe Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Drug Type
  • Figure 127: Europe Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Route of Administration
  • Figure 128: Europe Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Indication
  • Figure 129: Europe Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Distribution Channel
  • Figure 130: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 131: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 132: China Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 133: China Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 134: Australia Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 135: Australia Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 136: India Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 137: India Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by 2018-2026
  • Figure 138: Rest of APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 139: Rest of APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 140: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Anti-VEGF, 2013-2017
  • Figure 141: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Anti-VEGF, 2018-2026
  • Figure 142: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Corticosteroids, 2013-2017
  • Figure 143: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Corticosteroids, 2018-2026
  • Figure 144: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Immunosuppressant, 2013-2017
  • Figure 145: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Immunosuppressant, 2018-2026
  • Figure 146: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Biologics, 2013-2017
  • Figure 147: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Biologics, 2018-2026
  • Figure 148: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Others, 2018-2026
  • Figure 149: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Others, 2018-2026
  • Figure 150: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Oral Administration, 2013-2017
  • Figure 151: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Oral Administration, 2018-2026
  • Figure 152: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Parenteral Administration, 2013-2017
  • Figure 153: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Parenteral Administration, 2018-2026
  • Figure 154: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Topical Administration, 2013-2017
  • Figure 155: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Topical Administration, 2018-2026
  • Figure 156: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Non-infectious Uveitic Macular Edema, 2013-2017
  • Figure 157: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Non-infectious Uveitic Macular Edema, 2018-2026
  • Figure 158: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Diabetic Macular Edema, 2013-2017
  • Figure 159: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Diabetic Macular Edema, 2018-2026
  • Figure 160: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retinal Vein Occlusion With Macular Edema, 2013-2017
  • Figure 161: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retinal Vein Occlusion With Macular Edema, 2018-2026
  • Figure 162: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Hospital Pharmacies, 2013-2017
  • Figure 163: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2026
  • Figure 164: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retail Pharmacies, 2013-2017
  • Figure 165: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retail Pharmacies, 2018-2026
  • Figure 166: APAC Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Online Pharmacies, 2013-2017
  • Figure 167: APAC Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Online Pharmacies, 2018-2026
  • Figure 168: APAC Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Country
  • Figure 169: APAC Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Drug Type
  • Figure 170: APAC Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Route of Administration
  • Figure 171: APAC Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Indication
  • Figure 172: APAC Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Distribution Channel
  • Figure 173: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 174: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 175: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Anti-VEGF, 2013-2017
  • Figure 176: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Anti-VEGF, 2018-2026
  • Figure 177: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Corticosteroids, 2013-2017
  • Figure 178: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Corticosteroids, 2018-2026
  • Figure 179: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Immunosuppressant, 2013-2017
  • Figure 180: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Immunosuppressant, 2018-2026
  • Figure 181: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Biologics, 2013-2017
  • Figure 182: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Biologics, 2018-2026
  • Figure 183: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Others, 2013-2017
  • Figure 184: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Others, 2018-2026
  • Figure 185: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Oral Administration, 2013-2017
  • Figure 186: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Oral Administration, 2018-2026
  • Figure 187: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Parenteral Administration, 2013-2017
  • Figure 188: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Parenteral Administration, 2018-2026
  • Figure 189: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Topical Administration, 2013-2017
  • Figure 190: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Topical Administration, 2018-2026
  • Figure 191: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Non-infectious Uveitic Macular Edema, 2013-2017
  • Figure 192: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Non-infectious Uveitic Macular Edema, 2018-2026
  • Figure 193: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Diabetic Macular Edema, 2013-2017
  • Figure 194: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Diabetic Macular Edema, 2018-2026
  • Figure 195: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retinal Vein Occlusion With Macular Edema, 2013-2017
  • Figure 196: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retinal Vein Occlusion With Macular Edema, 2018-2026
  • Figure 197: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Hospital Pharmacies, 2013-2017
  • Figure 198: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2026
  • Figure 199: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retail Pharmacies, 2013-2017
  • Figure 200: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retail Pharmacies, 2018-2026
  • Figure 201: Japan Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Online Pharmacies, 2013-2017
  • Figure 202: Japan Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Online Pharmacies, 2018-2026
  • Figure 203: Japan Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Drug Type
  • Figure 204: Japan Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Route of Administration
  • Figure 205: Japan Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Indication
  • Figure 206: Japan Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Distribution Channel
  • Figure 207: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 208: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 209: GCC Countries Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 210: GCC Countries Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 211: South Africa Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 212: South Africa Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 213: Rest of MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, 2013-2017
  • Figure 214: Rest of MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 215: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Anti-VEGF, 2013-2017
  • Figure 216: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Anti-VEGF, 2018-2026
  • Figure 217: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Corticosteroids, 2013-2017
  • Figure 218: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Corticosteroids, 2018-2026
  • Figure 219: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Immunosuppressant, 2013-2017
  • Figure 220: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Immunosuppressant, 2018-2026
  • Figure 221: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Biologics, 2013-2017
  • Figure 222: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Biologics, 2018-2026
  • Figure 223: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Others, 2013-2017
  • Figure 224: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Others, 2018-2026
  • Figure 225: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Oral Administration, 2013-2017
  • Figure 226: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Oral Administration, 2018-2026
  • Figure 227: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Parenteral Administration, 2013-2017
  • Figure 228: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Parenteral Administration, 2018-2026
  • Figure 229: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Topical Administration, 2013-2017
  • Figure 230: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Topical Administration, 2018-2026
  • Figure 231: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Non-infectious Uveitic Macular Edema, 2013-2017
  • Figure 232: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Non-infectious Uveitic Macular Edema, 2018-2026
  • Figure 233: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Diabetic Macular Edema, 2013-2017
  • Figure 234: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Diabetic Macular Edema, 2018-2026
  • Figure 235: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retinal Vein Occlusion With Macular Edema, 2013-2017
  • Figure 236: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retinal Vein Occlusion With Macular Edema, 2018-2026
  • Figure 237: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Hospital Pharmacies, 2013-2017
  • Figure 238: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2026
  • Figure 239: MEA Non-infectious Macular Edema Treatment Market Size (US$ Mn) Analysis, by Retail Pharmacies, 2013-2017
  • Figure 240: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Retail Pharmacies, 2018-2026
  • Figure 241: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Online Pharmacies, 2013-2017
  • Figure 242: MEA Non-infectious Macular Edema Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), by Online Pharmacies, 2018-2026
  • Figure 243: MEA Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Country
  • Figure 244: MEA Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Drug Type
  • Figure 245: MEA Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Route of Administration
  • Figure 246: MEA Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Indication
  • Figure 247: MEA Non-infectious Macular Edema Treatment Attractiveness Analysis 2018-2026, By Distribution Channel
  • Figure 248: Global Non-infectious Macular Edema Treatment Market Attractiveness Analysis By Region, 2018-2026
  • Figure 249: Global Non-infectious Macular Edema Treatment Market Attractiveness Analysis By Drug Type, 2018-2026
  • Figure 250: Global Non-infectious Macular Edema Treatment Market Attractiveness Analysis By Route of Administration, 2018-2026
  • Figure 251: Global Non-infectious Macular Edema Treatment Market Attractiveness Analysis By Indication, 2018-2026
  • Figure 252: Global Non-infectious Macular Edema Treatment Market Attractiveness Analysis By Distribution Channel, 2018-2026
  • Figure 253: Global Non-infectious Macular Edema Treatment Market Value Analysis and Forecast, 2017-2026 (US$ Mn)
  • Figure 254: Global Non-infectious Macular Edema Treatment Market Value (US$ Mn), 2013-2017
  • Figure 255: Global Non-infectious Macular Edema Treatment Market Absolute $ Opportunity (US$ Mn), 2018-2026
Back to Top